3 More Medtech Stocks for Your Watch List
The respiratory disease market is massive, and it just keeps getting bigger. The good news for investors and patients is that there are plenty of companies working to get relief to sufferers of sleep apnea, COPD, asthma, lung cancer, and more. In this week's episode of Industry Focus: Healthcare, host Shannon Jones chats with fool.com's Brian Feroldi about three respiratory disease medtech companies -- Inogen (NASDAQ: INGN), ResMed (NYSE: RMD), and Inspire Medical (NYSE: INSP). Find out how ResMed could be exploding their market opportunity in a huge way soon, how Inspire Medical is winning over CPAP non-compliant patients, why Inogen's beaten-down stock price should make investors take a second look, and much more.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. A full transcript follows the video.
Source Fool.com
